AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOTECH

Transaction in Own Shares Apr 25, 2014

9301_rns_2014-04-25_bc1495f2-e511-455c-a3ed-7b6607449624.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares

PR Newswire

London, April 25

                                                      For immediate release                                                                  25 April 2014                         THE BIOTECH GROWTH TRUST PLC                                (the "Company")                    MARKET PURCHASE OF COMPANY'S OWN SHARESNotification is given, pursuant to the authority granted at the Annual GeneralMeeting of the Company held on 9 July 2013 to make market purchases of theCompany's own shares up to an aggregate maximum of 10,212,888 that a markettotal of 72,316 Ordinary shares of 25p each in the capital of the Company werepurchased today by the Company at a price of 434.14p per share. These shareswill be held in treasury.Following this transaction and in conformity with the provisions of theTransparency Directive, the Company hereby notifies the market that theresultant number of Ordinary shares held by the Company in treasury is 769,437and the total number of Ordinary shares that the Company has in issue is68,886,347 so that the total number of voting rights in the Company followingthe repurchase is 68,116,910.The figure of 68,116,910 may be used by shareholders as the denominator for thecalculation by which they may determine if they are required to notify theirinterest in, or change to their interest in, the Company under the FCA'sDisclosure and Transparency Rules.For and on behalf ofFrostrow Capital LLPCompany SecretaryFor further information, please contact:Mark PopeFrostrow Capital LLP

Tel: 020 3 008 4913

Talk to a Data Expert

Have a question? We'll get back to you promptly.